Report - PHARMSTANDARD –LEADING RUSSIAN PHARMACEUTICAL COMPANY · 5 H1 2014 Sales Structure (excl. spin-off effect) Pharmaceutical products 90,6% OTC 54% TPP 42,1% Rx 46% Medical equipment

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form